Skip to main content
Log in

Disposition of synthetic glucocorticoids I. Pharmacokinetics of dexamethasone in healthy adults

  • Published:
Journal of Pharmacokinetics and Biopharmaceutics Aims and scope Submit manuscript

Abstract

The pharmacokinetics of dexamethasone alcohol is described in six male and six female healthy adult volunteers who each received 8 mg of dexamethasone phosphate by bolus intravenous injection. Quantitation of the alcohol was done using a high-performance liquid Chromatographic method with improved specificity. Statistical evaluation of the results generated by nonlinear least-squares regression analysis of the plasma concentration-time data shows that the phosphate ester is very rapidly hydrolyzed to the alcohol and a biexponential equation is the simplest poly exponential equation that is consistent with the data. The terminal phase half-lifet 1/2β was significantly greater (p<0.05) in males (mean 201.5 min) than in females (mean 142.3 min). The prolongedt 1/2β in males did not appear to be caused by an impaired capacity to eliminate dexamethasone since the total plasma clearance did not differ between males (mean 247.5ml/min) and females (mean 242.9 ml/min). There was, however, a high positive correlation betweent 1/2β and\(V_{d_{ss} } \) among the 12 adults (r=0.92, p<0.001). There were also significant correlations between\(V_{d_{ss} } \) and body weight (r=0.67, p<0.05) andt 1/2β (r=0.80, p<0.01).The difference in body weight between the sexes seems to be the main factor contributing to the difference observed in t 1/2β. An average of only 2.6% of the dose was found unchanged in a 24-hr urine sample, and hence it appears that dexamethasone is primarily eliminated by extrarenal, probably hepatic, mechanisms.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. G. C. Liggins and R. N. Howie. The prevention of RDS by maternal steroid therapy. In L. Gluck (ed.),Modern Perinatal Medicine, Year Book Medical Publishers, Chicago, 1974, pp. 415–424.

    Google Scholar 

  2. E. Caspi, P. Schreyer, Z. Weinraub, R. Reif, I. Levi, and G. Mundel. Prevention of the respiratory distress syndrome in premature infants by antepartum glucocorticoid therapy.Br. J. Obstet. Gynaecol. 83:187–193 (1976).

    Article  CAS  PubMed  Google Scholar 

  3. Y. Araki, O. Yokota, T. Kato, M. Kashima, and T. Miyazaki. Dynamics of synthetic corticosteroids in man. In G. Pincus, T. Nakao, and J. F. Tait (eds.),Steroid Dynamics, Academic Press, New York, 1966, pp. 463–480.

    Chapter  Google Scholar 

  4. S. M. Brooks, E. E. Werk, S. J. Ackerman, I. Sullivan, and K. Thrasher. Adverse effects of phenobarbital on corticosteroid metabolism in patients with bronchial asthma.New Engl. J. Med. 286:1125–1128 (1972).

    Article  CAS  PubMed  Google Scholar 

  5. N. Haque, K. Thrasher, E. E. Werk, H. C. Knowles, and L. J. Sholiton. Studies on dexamethasone metabolism in man: Effect of diphenylhydantoin.J. Clin. Endocrinol. 34:44–50 (1972).

    Article  CAS  Google Scholar 

  6. M. Hichens and A. F. Hogans. Radioimmunoassay for dexamethasone in plasma.Clin. Chem. 20:266–271 (1974).

    CAS  PubMed  Google Scholar 

  7. A. W. Meikle, L. G. Lagerquist, and F. H. Tyler. A plasma dexamethasone radioimmunoassay.Steroids 22:193–202 (1973).

    Article  CAS  PubMed  Google Scholar 

  8. J. English, J. Chakraborty, V. Marks, and A. Parke. A radioimmunoassay procedure for dexamethasone—Plasma and urine level in man.Eur. J. Clin. Pharmacol. 9:239–244 (1975).

    Article  CAS  PubMed  Google Scholar 

  9. D. E. Duggan, K. C. Yeh, N. Matalia, C. A. Ditzler, and F. G. McMahon. Bioavailability of oral dexamethasone.Clin. Pharmacol. Ther. 18:205–209 (1975).

    CAS  PubMed  Google Scholar 

  10. L. E. Hare, K. C. Yeh, C. A. Ditzler, F. G. McMahon, and D. E. Duggan. Bioavailability of dexamethasone. II. Dexamethasone phosphate.Clin. Pharmacol. Ther. 18:330–337 (1975).

    CAS  PubMed  Google Scholar 

  11. S. E. Tsuei, J. J. Ashley, R. G. Moore, and W. G. McBride. Quantitation of dexamethasone in biological fluids using high performance liquid chromatography.J. Chromatog. Biomed. Appl. 145:213–220 (1978).

    Article  CAS  Google Scholar 

  12. P. Veng Pedersen. Funfit Manual, Pharmacy Department, University of Sydney, Australia, 1976.

    Google Scholar 

  13. H. G. Boxenbaum, S. Riegelman, and R. M. Elashoff. Statistical estimations in pharmacokinetics.J. Pharmacokin. Biopharm. 2:123–148 (1974).

    Article  CAS  Google Scholar 

  14. J. G. Wagner. Linear pharmacokinetic equations allowing direct calculation of many needed pharmacokinetic parameters from the coefficients and exponents of poly-exponential equations which have been fitted to the data.J. Pharmacokin. Biopharm. 4:443–467 (1976).

    Article  CAS  Google Scholar 

  15. A. Goldstein.Biostatistics: An Introductory Text, Macmillan, New York, 1964, pp. 55–58.

    Google Scholar 

  16. D. Perrier and M. Gibaldi. Clearance and biologic half-life as indices of intrinsic hepatic metabolism.J. Pharmacol. Exp. Ther. 191:17–24 (1974).

    CAS  PubMed  Google Scholar 

  17. S. E. Bradley, F. J. Ingelfinger, G. P. Bradley, and J. J. Curry. The estimation of hepatic blood flow in man.J. Clin. Invest. 24:890–897 (1945).

    Article  PubMed Central  Google Scholar 

  18. M. Rowland, L. Z. Benet, and G. G. Graham. Clearance concepts in pharmacokinetics.J. Pharmacokin. Biopharm. 1:123–136 (1973).

    Article  CAS  Google Scholar 

  19. G. R. Wilkinson and D. G. Shand. A physiological approach to hepatic drug clearance.Clin. Pharmacol. Ther. 18:377–390 (1975).

    CAS  PubMed  Google Scholar 

  20. T. F. Blaschke. Protein binding and kinetics of drugs in liver disease.Clin. Pharmacokin. 2:32–44 (1977).

    Article  CAS  Google Scholar 

  21. E. A. Peets, M. Slaub, and S. Symchowicz. Plasma binding of betamethasone-3H, dexamethasone-3H, and cortisol-14C: A comparative study.Biochem. Pharmacol. 18:1655–1663 (1969).

    Article  CAS  PubMed  Google Scholar 

  22. K. Diem and C. Lentner.Scientific Tables, Ciba-Geigy Ltd., Basel, 1971, p. 576.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Tsuei, S.E., Moore, R.G., Ashley, J.J. et al. Disposition of synthetic glucocorticoids I. Pharmacokinetics of dexamethasone in healthy adults. Journal of Pharmacokinetics and Biopharmaceutics 7, 249–264 (1979). https://doi.org/10.1007/BF01060016

Download citation

  • Received:

  • Revised:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01060016

Key words

Navigation